Reckitt Benckiser in Consumer Health

February 2023

Reckitt Benckiser (RB) has strengthened its position in 2022, gaining a place to become the world’s sixth largest consumer health company driven by strong performance in the US and the UK. Growth has been driven by brand development and customer expansion, mainly within OTC and VDS as RB is continuing to focus on its core brands. Commitments to sustainability and the consumer continue to be the guiding elements behind RB’s strategy for the coming years.

USD 570
Request More Information

Delivery: 

Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).

This report comes in PPT.

Overview:

Euromonitor International's report on Reckitt Benckiser delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Reckitt Benckiser, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Reckitt Benckiser.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Reckitt Benckiser provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Download Table of Contents
Executive summary
Scope
Reckitt Benckiser overtakes Amway Corp in 2022
North America and Western Europe are key regions for Reckitt Benckiser
OTC remains RB’s leading category and the US remains the largest market
RB benefits from growth in all areas, led by market momentum
US remains the key source of growth for Reckitt Benckiser over the forecast period
RB’s shares and sales increased among mixed performance of competitors
Reckitt Benckiser continues to experience a significant overlap with Haleon
Reckitt Benckiser’s top 10 countries cover all regions
Nurofen remains a top brand for Reckitt Benckiser in many important markets
The US and the UK remain key markets for RB
RB’s sustainability goals
Attitudes towards preventative health indicate opportunity for innovation and diversification
Women’s health becoming a key business unit for Reckitt Benckiser
Western Europe and North America are the main markets for RB’s OTC portfolio
CCA and analgesics remain dominant due to the resurgence of colds and flus
OTC offers significant opportunities for growth across markets
Gaviscon performs well despite ingredient shortages and supply issues
Asia Pacific represents a new market opportunity for VDS
Dietary supplements remains the largest contributor to overall sales value in VDS
China represents a large opportunity for VDS value growth outside the US
Key findings
Projected company sales: FAQs (1/2)
Projected company sales: FAQs (2/2)
Overview of Beauty Survey

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions
Share:

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!

© 2023 Euromonitor is privately owned & trademarked. VAT No. GB: 239-2559-40 Registered in England No. 1040587
;